Should the terminally ill have the RIGHT-TO-TRY non-FDA approved therapies?

“Five years ago, the phrase “right to try” wasn’t yet an inkling in the minds of its staunchest advocates. Today, the pithy shorthand for the campaign to get dying patients access to experimental treatments has been slapped on bumper stickers, emblazoned on T-shirts, and uttered by some of the most powerful figures in Washington… But

Read more ›

With recurring infection should Congressman Scalise have been transferred to another hospital rather than to the ICU where he is hospitalized?

About twenty years ago as President of LibertyHealth each of our hospitals (a medical school affiliated teaching hospital and two community hospitals) had an ICU. I was always concerned that sometimes patient acuity in one of the community hospital ICUs might have exceeded its capability and pushed for clear clinical threshholds for patient transfer to

Read more ›

The PSA experts’ kerfuffle! Is there an evidence-based algorithm?

Recently I was listening to a health call-in show on public radio during which a urologist gave advice on the diagnosis protocol for prostate cancer seemingly different and more aggressive from the one used by my urologist. I remember when the “gold standard” for PSA prostate screening was a score of 4 or below. Then

Read more ›